ClinVar Miner

Submissions for variant NM_000214.3(JAG1):c.3528C>T (p.Tyr1176=)

gnomAD frequency: 0.22213  dbSNP: rs1051421
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035333 SCV000058981 benign not specified 2016-03-30 criteria provided, single submitter clinical testing p.Tyr1176Tyr in exon 26 of JAG1: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 28% (18682/66732) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs1051421).
PreventionGenetics, part of Exact Sciences RCV000035333 SCV000303028 benign not specified criteria provided, single submitter clinical testing
Ambry Genetics RCV000245407 SCV000317524 benign Cardiovascular phenotype 2015-06-24 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Illumina Laboratory Services, Illumina RCV000359120 SCV000432880 benign Isolated Nonsyndromic Congenital Heart Disease 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Invitae RCV001516691 SCV001725006 benign Alagille syndrome due to a JAG1 point mutation 2024-01-31 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001730480 SCV001980822 benign Deafness, congenital heart defects, and posterior embryotoxon 2021-08-19 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001516691 SCV001980825 benign Alagille syndrome due to a JAG1 point mutation 2021-08-19 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001730479 SCV001980826 benign Tetralogy of Fallot 2021-08-19 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000035333 SCV003928852 benign not specified 2023-04-04 criteria provided, single submitter clinical testing
Clinical Genetics, Academic Medical Center RCV000035333 SCV001919470 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000035333 SCV001959923 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.